← Back to headlines
AbCellera Stock Rises Ahead of Phase 2 Menopause Asset Results
AbCellera's stock has seen an increase as the company prepares to release the phase 2 results for its menopause asset, generating investor interest.
7 Aug, 21:06 — 7 Aug, 21:06
Sources
Showing 1 of 1 sources
